ATP III GP, Ltd.

CIK 1593453 · last filed 2020-07-14

ATP III GP, Ltd. is a corporate insider who has filed 2 SEC Form 4 insider transactions across 2 companies since 2015. The most recent filing shows the insider bought $29.9M of AKRO on Jul 14, 2020. Across all open-market trades the lifetime net is +$29.9M, making them a net buyer over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

2

Lifetime Open-Market Net

$29.88M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Akero Therapeutics, Inc. (AKRO) Delisted 10%+ Owner 5,830,203 $54.65 $318.62M $29.88M 1 2020-07-14
Avalo Therapeutics, Inc. (CERC.U) Delisted Director 595,436 $0 1 2015-10-20

Recent Filings

2 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2020-07-14 Akero Therapeutics, Inc. (AKRO) Delisted Buy (P) +830,000 $29.88M EDGAR
2015-10-20 Avalo Therapeutics, Inc. (CERC.U) Delisted Conv (C) +1,786,308 $0 EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.